ID: PMRREP27310
Format: PPT*, PDF, EXCEL
Last Updated: 18 May 2022
Industry: Healthcare
Number of Pages: 198
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Disorder Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Introduction
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Global Circadian Rhythm Sleep Treatment Market Key Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation Trends
3.3. Innovations & New Launches
3.4. Disease Overview and Epidemiology (Prevalence Data), by Region
4. Global Circadian Rhythm Sleep Treatment Market Key Success Factors
4.1. Product Adoption / Awareness Analysis
4.2. Product Features Vs. Disorder Matrix
5. Global Circadian Rhythm Sleep Treatment Market – Pricing Analysis
5.1. Regional Pricing Analysis
5.2. Pricing Break-Up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Circadian Rhythm Sleep Treatment Market Demand Analysis 2013-2021 and Forecast, 2022 - 2026
6.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022 - 2026
6.3. Y-o-Y Growth Trend Analysis
7. Global Circadian Rhythm Sleep Treatment Market Context
7.1. Key Regulations
7.2. Macro-Economic Factors
7.3. Forecast Factors – Relevance & Impact
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Opportunity Analysis
8. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Treatment Type
8.1. Introduction/Key Finding
8.1.1. Market Size (US$ Mn) and Volume Share Analysis By Treatment Type
8.1.2. Y-o-Y Growth Analysis By Treatment Type
8.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Treatment Type, 2013-2021
8.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Treatment Type, 2022 - 2026
8.3.1. Devices
8.3.1.1. Therapeutic Devices
8.3.1.1.1. Light Box
8.3.1.1.2. Desk Lamps
8.3.1.1.3. Light Visor
8.3.1.1.4. Dawn Simulator
8.3.1.2. Diagnostic Devices
8.3.1.2.1. Actigraphy Sensors
8.3.1.2.1.1. Wrist and Hand band Actigraphy Devices
8.3.1.2.1.2. Wearable Actigraphy Devices
8.3.1.2.2. Polysomnography Devices
8.3.1.2.2.1. Fixed Polysomnography Devices
8.3.1.2.2.2. Portable Polysomnography Devices
8.3.2. Drugs
8.3.2.1. Benzodiazepines
8.3.2.2. Nonbenzodiazepine hypnotics
8.3.2.3. Orexin receptor antagonists
8.3.2.4. Melatonin receptor agonist
8.3.3. Chronotherapy
8.4. Market Attractiveness Analysis By Treatment Type
9. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Disorder
9.1. Introduction/Key Finding
9.1.1. Market Size (US$ Mn) Analysis By Disorder
9.1.2. Y-o-Y Growth Analysis By Disorder
9.2. Historical Market Size (US$ Mn) Analysis By Disorder , 2013-2021
9.3. Market Size (US$ Mn) Forecast By Disorder , 2022 - 2026
9.3.1. Delayed Sleep Phase Syndrome (DSPS)
9.3.2. Advanced Sleep Phase Syndrome (ASPS)
9.3.3. Non–24-h Sleep-Wake Syndrome
9.3.4. Irregular Sleep-Wake Disorder (ISWD)
9.3.5. Shift Work Disorder
9.3.6. Jet Lag
9.4. Market Attractiveness Analysis By Disorder
10. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Distribution Channel
10.1. Introduction/Key Finding
10.1.1. Market Size (US$ Mn) Analysis By Distribution Channel
10.1.2. Y-o-Y Growth Analysis By Distribution Channel
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2021
10.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022 - 2026
10.3.1. Institutional Sales
10.3.1.1. Home Care Settings
10.3.1.2. Wellness Centers & Spa
10.3.1.3. Sleep Testing Centers
10.3.1.4. Specialty Clinics
10.3.1.5. Hospitals
10.3.2. Retail Sales
10.3.2.1. Retail Pharmacies
10.3.2.2. Drug Stores
10.3.2.3. Online Sales
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Region
11.1. Introduction/Key Finding
11.1.1. Market Size (US$ Mn) and Volume Share Analysis By Region
11.1.2. Y-o-Y Growth Analysis By Region
11.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Region, 2013-2021
11.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Region, 2022 - 2026
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
12.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Treatment Type
12.3.3. By Disorder
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment Type
12.4.3. By Disorder
12.4.4. By Distribution Channel
12.5. Drivers and Restraints: Impact Analysis
12.6. Key Market Participants – Intensity Mapping
13. Latin America Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
13.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Treatment Type
13.3.3. By Disorder
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment Type
13.4.3. By Disorder
13.4.4. By Distribution Channel
13.5. Drivers and Restraints: Impact Analysis
13.6. Key Market Participants – Intensity Mapping
14. Europe Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
14.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
14.3.1. By Country
14.3.1.1. U.K.
14.3.1.2. Germany
14.3.1.3. France
14.3.1.4. Italy
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Nordic
14.3.1.8. Poland
14.3.1.9. Rest of Europe
14.3.2. By Treatment Type
14.3.3. By Disorder
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment Type
14.4.3. By Disorder
14.4.4. By Distribution Channel
14.5. Drivers and Restraints: Impact Analysis
14.6. Key Market Participants – Intensity Mapping
15. East-Asia Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
15.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.1.4. Rest of East Asia
15.3.2. By Treatment Type
15.3.3. By Disorder
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment Type
15.4.3. By Disorder
15.4.4. By Distribution Channel
15.5. Drivers and Restraints: Impact Analysis
15.6. Key Market Participants – Intensity Mapping
16. South Asia Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
16.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Malaysia
16.3.1.4. Indonesia
16.3.1.5. Philippines
16.3.1.6. Rest of South Asia
16.3.2. By Treatment Type
16.3.3. By Disorder
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Treatment Type
16.4.3. By Disorder
16.4.4. By Distribution Channel
16.5. Drivers and Restraints: Impact Analysis
16.6. Key Market Participants – Intensity Mapping
17. Oceania Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
17.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Treatment Type
17.3.3. By Disorder
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Treatment Type
17.4.3. By Disorder
17.4.4. By Distribution Channel
17.5. Drivers and Restraints: Impact Analysis
17.6. Key Market Participants – Intensity Mapping
18. MEA Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
18.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Iran
18.3.1.3. Israel
18.3.1.4. Turkey
18.3.1.5. Rest of MEA
18.3.2. By Treatment Type
18.3.3. By Disorder
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Treatment Type
18.4.3. By Disorder
18.4.4. By Distribution Channel
18.5. Drivers and Restraints: Impact Analysis
18.6. Key Market Participants – Intensity Mapping
19. Competition Analysis
19.1. Competition Dashboard
19.2. Pricing Analysis, By Competition
19.3. Competition Benchmarking
19.4. Gross Margin Analysis, By Competition
19.5. Competition Developments
19.6. Competition Deep Dive
19.6.1. Vanda Pharmaceuticals Inc.
19.6.1.1. Overview
19.6.1.2. Product and Disorder Portfolio
19.6.1.3. Production Footprint
19.6.1.4. Sales Footprint
19.6.1.5. Strategy
19.6.1.5.1. Marketing Strategy
19.6.1.5.2. Product Strategy
19.6.1.5.3. Channel Strategy
19.6.2. Natus Medical Incorporated
19.6.2.1. Overview
19.6.2.2. Product and Disorder Portfolio
19.6.2.3. Production Footprint
19.6.2.4. Sales Footprint
19.6.2.5. Strategy
19.6.2.5.1. Marketing Strategy
19.6.2.5.2. Product Strategy
19.6.2.5.3. Channel Strategy
19.6.3. Compumedics Ltd.
19.6.3.1. Overview
19.6.3.2. Product and Disorder Portfolio
19.6.3.3. Production Footprint
19.6.3.4. Sales Footprint
19.6.3.5. Strategy
19.6.3.5.1. Marketing Strategy
19.6.3.5.2. Product Strategy
19.6.3.5.3. Channel Strategy
19.6.4. Teva Pharmaceutical Industries Ltd
19.6.4.1. Overview
19.6.4.2. Product and Disorder Portfolio
19.6.4.3. Production Footprint
19.6.4.4. Sales Footprint
19.6.4.5. Strategy
19.6.4.5.1. Marketing Strategy
19.6.4.5.2. Product Strategy
19.6.4.5.3. Channel Strategy
19.6.5. Takeda Pharmaceutical Company
19.6.5.1. Overview
19.6.5.2. Product and Disorder Portfolio
19.6.5.3. Production Footprint
19.6.5.4. Sales Footprint
19.6.5.5. Strategy
19.6.5.5.1. Marketing Strategy
19.6.5.5.2. Product Strategy
19.6.5.5.3. Channel Strategy
19.6.6. Koninklijke Philips N.V
19.6.6.1. Overview
19.6.6.2. Product and Disorder Portfolio
19.6.6.3. Production Footprint
19.6.6.4. Sales Footprint
19.6.6.5. Strategy
